UBE2T and hepatocellular carcinoma: Recent studies have discovered that UBE2T is significantly increased in hepatocellular carcinoma, gallbladder cancer, and gastric cancer, and its high expression is closely associated with the tumor size, metastasis, and poor prognosis, suggesting that UBE2T may have the potential to promote the proliferation, invasion, and metastasis of malignant tumors [13–15].